Corbus Pharmaceuticals' Unattributed - II Round

Corbus Pharmaceuticals raised a round of funding on March 12, 2014.

Corbus Pharmaceuticals is a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat life threatening ("orphan") inflammatory-fibrotic d…

Articles about Corbus Pharmaceuticals' Unattributed - II Round: